| Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents WF Hsu, HC Lai, WP Su, CH Lin, PH Chuang, SH Chen, HY Chen, ... BMC gastroenterology 19, 1-9, 2019 | 83 | 2019 |
| The clinical characteristics and manifestations of cytomegalovirus esophagitis HW Wang, CJ Kuo, WR Lin, CM Hsu, YP Ho, CJ Lin, MY Su, CT Chiu, ... Diseases of the Esophagus 29 (4), 392-399, 2016 | 71 | 2016 |
| New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis HW Wang, CY Peng, HC Lai, WP Su, CH Lin, PH Chuang, SH Chen, ... Scientific reports 7 (1), 3259, 2017 | 52 | 2017 |
| The trend of inflammatory bowel diseases in Taiwan: a population-based study CJ Kuo, KH Yu, LC See, CT Chiu, MY Su, CM Hsu, CF Kuo, MJ Chiou, ... Digestive diseases and sciences 60, 2454-2462, 2015 | 41 | 2015 |
| Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C SH Chen, HC Lai, IP Chiang, WP Su, CH Lin, JT Kao, PH Chuang, ... PLoS One 13 (1), e0190455, 2018 | 29 | 2018 |
| Performance of acoustic radiation force impulse elastography for staging liver fibrosis in patients with chronic hepatitis C after viral eradication SH Chen, HC Lai, IP Chiang, WP Su, CH Lin, JT Kao, PH Chuang, ... Clinical Infectious Diseases 70 (1), 114-122, 2020 | 28 | 2020 |
| Clinical characteristics and manifestation of herpes esophagitis: one single-center experience in Taiwan HW Wang, CJ Kuo, WR Lin, CM Hsu, YP Ho, CJ Lin, MY Su, CT Chiu, ... Medicine 95 (14), e3187, 2016 | 24 | 2016 |
| Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience WF Hsu, PH Chuang, CK Chen, HW Wang, MH Tsai, WP Su, HY Chen, ... American Journal of Cancer Research 10 (12), 4547, 2020 | 19 | 2020 |
| Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine … WF Hsu, HW Wang, CK Chen, HC Lai, PH Chuang, MH Tsai, WP Su, ... American Journal of Cancer Research 11 (12), 6173, 2021 | 13 | 2021 |
| On-treatment changes in FIB-4 and 1-year FIB-4 values help identify patients with chronic hepatitis B receiving entecavir therapy who have the lowest risk of hepatocellular … HW Wang, HC Lai, TH Hu, WP Su, SN Lu, CH Lin, CH Hung, PH Chuang, ... Cancers 12 (5), 1177, 2020 | 13 | 2020 |
| Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy HW Wang, HC Lai, TH Hu, WP Su, SN Lu, CH Lin, CH Hung, PH Chuang, ... Journal of Gastroenterology and Hepatology 34 (2), 442-449, 2019 | 13 | 2019 |
| On-treatment albumin-bilirubin grade: predictor of response and outcome of sorafenib-regorafenib sequential therapy in patients with unresectable hepatocellular carcinoma HW Wang, PH Chuang, WP Su, JT Kao, WF Hsu, CC Lin, GT Huang, ... Cancers 13 (15), 3758, 2021 | 12 | 2021 |
| Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long‐term nucleos (t) ide analogue therapy WF Hsu, CF Chen, HC Lai, WP Su, CH Lin, PH Chuang, SH Chen, ... Liver International 38 (4), 627-635, 2018 | 11 | 2018 |
| Liver fibrosis regression correlates with downregulation in liver angiogenesis in chronic hepatitis C through viral eradication SH Chen, CL Huang, IP Chiang, TC Chang, HW Wang, WF Hsu, TY Tsai, ... European Journal of Gastroenterology & Hepatology 33 (9), 1209-1217, 2021 | 7 | 2021 |
| Serum miR-21 correlates with the histological stage of chronic hepatitis B-associated liver fibrosis HC Wu, CL Huang, HW Wang, WF Hsu, TY Tsai, SH Chen, CY Peng International journal of clinical and experimental pathology 12 (10), 3819, 2019 | 7 | 2019 |
| Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral … WF Hsu, HC Lai, PH Chuang, WP Su, SH Chen, HY Chen, HW Wang, ... Journal of Viral Hepatitis 29 (9), 785-794, 2022 | 4 | 2022 |
| Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma WF Hsu, KC Chang, TH Chen, CH Lin, YC Lin, MH Tsai, PY Chen, ... Medicine 100 (33), e27000, 2021 | 4 | 2021 |
| Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade … WF Hsu, HC Lai, CK Chen, HW Wang, PH Chuang, MH Tsai, SH Chen, ... American Journal of Cancer Research 13 (2), 654, 2023 | 3 | 2023 |
| Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a … HW Wang, PC Tsai, CY Chen, KC Tseng, HC Lai, HT Kuo, CH Hung, ... American Journal of Cancer Research 12 (7), 3164, 2022 | 3 | 2022 |
| MO5-4 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors YY Su, WH Lee, JH Wang, HW Wang, TW Chen, BB Chen, HJ Ho, TH Liu, ... Annals of Oncology 33, S484, 2022 | 2 | 2022 |
